drugset / Trial / NCT00004045

Chemotherapy in Treating Patients With Prostate Cancer

NCT00004045

Phase 2 Completed Daiichi Sankyo
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DX-8951f in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Timeline

Start
1999-06
Primary completion
2001-08
Completion
2001-08

Drugs

EvaluationDrugModalityDoseRoute
Subject exatecan Small molecule Intravenous

Indications